Clinical Trials Logo
  1. Home
  2. SMA
  3. NCT06322654

A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal Muscular Atrophy) Patients — SMArt  

SMA Clinical Trial

Official title:
A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA Patients: Single-center, Randomized, Single-blinded, Comparative Study of a Robotically Active Verticalization Model Versus Robotically Assisted Locomotion Model

Clinical Trial Summary

A head-to-head study comparing the functional value of two models of robotically assisted rehabilitation in patients with SMA. A single-center, randomized, single-blinded, comparative study of Robotically Assisted Verticalization versus Robotically Assisted Locomotion. The objective of research: The main goal of the project is to determine the optimal robotically assisted rehabilitation model for people with SMA depending on age and baseline functional status. The study consists of a head-to-head comparison of two rehabilitation models. 1. Research period: 4 years 2. Patients age: 0-21 y.o. 3. Group size: 200 patients (100 patients in each group) 4. Assignment of patients to study groups in a randomised manner

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06322654
Study type Interventional
Source Wiktor Dega University Orthopedic and Rehabilitation Hospital
Contact Marek Józwiak
Phone 696052475
Email sma@orsk.pl
Status Recruiting
Phase N/A
Start date December 21, 2023
Completion date July 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04825119 - Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen
Not yet recruiting NCT06300996 - Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb N/A
Recruiting NCT05102916 - Swiss Registry for Neuromuscular Disorders
Active, not recruiting NCT05337553 - A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy Phase 3
Recruiting NCT04292574 - UK SMA Patient Registry
Completed NCT01984957 - Differential Study of Muscle Transcriptome N/A
Completed NCT00774423 - Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) Phase 2/Phase 3
Active, not recruiting NCT05156320 - Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam Phase 3
Active, not recruiting NCT04042025 - Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Phase 3
Completed NCT02941328 - SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4 Phase 2
Completed NCT03461289 - Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 Phase 3
Completed NCT03921528 - An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy Phase 2
Active, not recruiting NCT05626855 - Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX Phase 3